Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMerck & Co Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 12 | -$1.59 | -$1.38 | -$1.47 |
| Q2 2026 | 4 | $2.03 | $2.19 | $2.11 |
| Q3 2026 | 4 | $2.25 | $2.33 | $2.29 |
| Q4 2026 | 2 | $1.96 | $2.06 | $2.00 |
| Q1 2027 | 2 | $2.09 | $2.20 | $2.13 |
| Q2 2027 | 1 | $2.23 | $2.34 | $2.27 |
| Q3 2027 | 1 | $2.62 | $2.75 | $2.67 |
| Q4 2027 | 2 | $2.45 | $2.57 | $2.50 |
Merck & Co Inc Earnings Date And Information
Merck & Co Inc last posted its earnings results on Thursday, April 30th, 2026. The company reported $-1.28 earnings per share for the quarter, topping analysts' consensus estimates of $-1.47 by $0.19. The company had revenue of 16.29 B for the quarter and had revenue of 64.93 B for the year. Merck & Co Inc has generated $7 earnings per share over the last year ($7.28 diluted earnings per share) and currently has a price-to-earnings ratio of 33.23. Merck & Co Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Merck & Co Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/04/2026 | Q1 2026 | N/A | -$1.72 | N/A | $15.85 B | $16.29 B |
| 02/24/2026 | Q4 2025 | N/A | $1.20 | N/A | $16.20 B | $16.32 B |
| 11/05/2025 | Q3 2025 | N/A | $2.32 | N/A | $16.98 B | $17.18 B |
| 08/05/2025 | Q2 2025 | N/A | $1.76 | N/A | $15.86 B | $15.80 B |
| 05/02/2025 | Q1 2025 | N/A | $2.01 | N/A | $15.34 B | $15.62 B |
| 02/25/2025 | Q4 2024 | N/A | $1.48 | N/A | $15.48 B | $15.62 B |
| 11/06/2024 | Q3 2024 | N/A | $1.25 | N/A | $16.47 B | $16.66 B |
| 08/05/2024 | Q2 2024 | N/A | $2.15 | N/A | $15.87 B | $16.11 B |
| 05/03/2024 | Q1 2024 | N/A | $1.88 | N/A | $15.21 B | $15.78 B |
| 02/26/2024 | Q4 2023 | N/A | -$0.48 | N/A | N/A | $14.63 B |
| 11/03/2023 | Q3 2023 | N/A | $1.87 | N/A | N/A | $15.96 B |
| 08/07/2023 | Q2 2023 | N/A | -$2.35 | N/A | N/A | $15.04 B |
| 05/05/2023 | Q1 2023 | N/A | $1.11 | N/A | N/A | $14.49 B |
| 02/24/2023 | Q4 2022 | N/A | $1.19 | N/A | N/A | $13.83 B |
| 11/03/2022 | Q3 2022 | N/A | $1.28 | N/A | N/A | $14.96 B |
| 08/04/2022 | Q2 2022 | N/A | $1.56 | N/A | N/A | $14.59 B |
| 05/05/2022 | Q1 2022 | N/A | $1.70 | N/A | N/A | $15.90 B |
| 02/25/2022 | Q4 2021 | N/A | $1.49 | N/A | N/A | $13.52 B |
| 11/05/2021 | Q3 2021 | N/A | $1.81 | N/A | N/A | $13.15 B |
| 08/09/2021 | Q2 2021 | N/A | $0.61 | N/A | N/A | $11.40 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Merck & Co Inc Earnings: FAQ's
In the previous quarter, Merck & Co Inc (:MRK) reported $-1.28 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.47 by $0.19.
The conference call for Merck & Co Inc's latest earnings report can be listened to online.
The conference call transcript for Merck & Co Inc's latest earnings report can be read online.
Merck & Co Inc (:MRK) has a recorded annual revenue of $64.93 B.
Merck & Co Inc (:MRK) has a recorded net income of $18.25 B.Merck & Co Inc has generated $7.3 earnings per share over the last four quarters.
Merck & Co Inc (:MRK) has a price-to-earnings ratio of 33.23 and price/earnings-to-growth ratio is -0.69.